National Health Expenditure forecasters see increases in cost per participant slowing somehwat, while employer spending will rise.

The Senate committee chair wants to know why the drugs cost up to 15 times more in the United States than elsewhere.

The physician group approved a resolution to advocate for detailed explanations for coverage denials, which leads to "patient harm."

An NYU professor complained at a hearing last year that from small deals big antitrust problems grow.

Amazon, Google and JPMorgan Chase — which have made entries into the health care sector — all have speakers on the AHIP 2024 agenda.

The state attorney general may get the authority to reject some of them. Two employer groups like that.

The plaintiffs rely extensively on a New York Times article that ran in April.

S&P Global analysts continue to see drug costs as the top everyday concern.